Key facts
- Genuform AI’s last known valuation is $540K (May 2024).
- It has raised $640K.
- Notable investors include Christian Szegedy, Creative Accelerator, Emmanuel Roth, Peter Balogh, STRT Holding — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Genuform AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Genuform AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genuform AI
Developer of an AI-powered knee cartilage matching system designed to optimize donor graft allocation in knee cartilage transplantation surgery. The company's AI system analyzes MR images to identify optimal graft shapes from a donor and precisely match them to the damaged regions in recipient patients, enabling patients to potentially increase the availability of suitable grafts, leading to improved surgical outcomes for a wider range.
- Sector
- Healthcare
- HQ
- Budapest, Hungary
- Employees
- 8
- Website
- genuform.ai/
- Ownership
- Privately Held (backing)
Genuform AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genuform AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genuform AI in its N-PORT filings yet. We sweep new filings monthly.